CSS to format presentations November 2021 Corporate Presentation lnk News Press Releases View All December 2, 2021 Codiak’s Engineered Exosomes Promote T Cell and Antibody Responses to SARS-CoV-2 in vivo, Supporting the Potential for a Broadly Protective Pan-Beta Coronavirus and Variant Vaccine December 1, 2021 Codiak BioSciences to Present at the 4th Annual Evercore ISI HealthCONx Conference November 30, 2021 Codiak BioSciences Announces FDA Clearance of IND for exoASO™-STAT6; Patient Dosing Expected 1H 2022 lnk Past Events Events View Past Events December 2, 2021 at 12:10 PM EST 4th Annual Evercore ISI HealthCONx Conference November 16, 2021 at 8:00 AM EST Codiak BioSciences exoSTING Phase 1/2 Data Readout
December 2, 2021 Codiak’s Engineered Exosomes Promote T Cell and Antibody Responses to SARS-CoV-2 in vivo, Supporting the Potential for a Broadly Protective Pan-Beta Coronavirus and Variant Vaccine
November 30, 2021 Codiak BioSciences Announces FDA Clearance of IND for exoASO™-STAT6; Patient Dosing Expected 1H 2022
